SHOCK US STUDY: Fluid Responsiveness in Sepsis Measured by Ultrasonography



Status:Completed
Conditions:Hospital
Therapuetic Areas:Other
Healthy:No
Age Range:18 - Any
Updated:6/17/2016
Start Date:August 2014
End Date:June 2016

Use our guide to learn which trials are right for you!

The study aim is to examine point-of-care ultrasound findings, reliability, and ease of
performance in association with fluid responsiveness for patients with severe sepsis and
septic shock. The investigators propose a prospective observational research study of
patients presenting to one of three Yale New Haven Hospital emergency departments, York
Street Campus, St. Raphael's Campus, and Shoreline Medical Center who meet criteria for
sepsis, severe sepsis or septic shock during their emergency department visit.

After each 1 Liter fluid challenge of IV fluid each outcome measure will be repeated to
determine if there is a change in ultrasound measures as patients undergo volume
resuscitation.

Inclusion Criteria:

- All patients age greater than 18 years who meet criteria of sepsis. Septic shock will
be defined as those patients with severe sepsis and persistent hypotension (<90mmHg
systolic blood pressure) despite a fluid challenge of at least 20cc/kg

- Patients will only be considered eligible for enrollment if the treating physician
plans to give at least 1-liter of crystalloid after initial US is performed

- A number (approximately 50 patients) with no symptoms of sepsis will be enrolled to
assess measurements in healthy patients. These patients will only have one ultrasound
performed for each of the desired study measures.

Exclusion Criteria:

- Patients unable to provide consent such as non-English speaking patients or
patient/health care proxy unable to give consent

- History of significant trauma

- Incarcerated patients

- Failure to complete fluid challenge

- Pericardial disease or heart transplant. Patients with left bundle branch block,
pulmonary hypertension, known systolic dysfunction (Ejection Fraction <40%),
receiving vasopressors, known moderate or severe valvular dysfunction, and irregular
heart rhythms will be enrolled but analyzed separately
We found this trial at
1
site
New Haven, Connecticut 6520
(203) 432-4771
Yale University Yale's roots can be traced back to the 1640s, when colonial clergymen led...
?
mi
from
New Haven, CT
Click here to add this to my saved trials